摘要
背景:人们普遍认为慢性炎症对癌症有重要的促进作用。癌症的免疫耐受介导肿瘤逃离免疫系统。炎症与免疫耐受关系的机制尚不完全阐明。 目的:本文考虑到炎症和耐受的主要机制,讨论了用于干预癌症炎症的药物靶点。 结论:炎症介导肿瘤诱导耐受。慢性炎症反应的诱导和维持是免疫耐受的普遍机制。
关键词: 炎症,分辨率,免疫耐受,肿瘤免疫治疗,肿瘤免疫,肿瘤诱导耐受。
图形摘要
Current Cancer Drug Targets
Title:The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer
Volume: 17 Issue: 4
关键词: 炎症,分辨率,免疫耐受,肿瘤免疫治疗,肿瘤免疫,肿瘤诱导耐受。
摘要: Background: It is widely accepted that chronic inflammation critically contributes to cancer. Immune tolerance in cancer mediates tumor escape from the immune system. The mechanisms of relations between inflammation and immune tolerance are still not fully elucidated.
Objective: The main mechanisms that link inflammation and tolerance are considered. Drug targets that are in use to interfere with inflammation in cancer are discussed. Conclusion: Inflammation mediates tumor-induced tolerance. The induction and the maintenance of the chronic inflammatory response is a universal mechanism of immune tolerance.Export Options
About this article
Cite this article as:
The Linkage Between Inflammation and Immune Tolerance: Interfering with Inflammation in Cancer, Current Cancer Drug Targets 2017; 17 (4) . https://dx.doi.org/10.2174/1568009617666170109110816
DOI https://dx.doi.org/10.2174/1568009617666170109110816 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Hot Topic: TRP Channels as Therapeutic Targets)
Current Topics in Medicinal Chemistry Garlic (<i>Allium sativum</i> L.): Its Chemistry, Nutritional Composition, Toxicity, and Anticancer Properties
Current Topics in Medicinal Chemistry Targeting Malignancies with Disulfiram (Antabuse): Multidrug Resistance, Angiogenesis, and Proteasome
Current Cancer Drug Targets Harnessing the Potential of Long Non-coding RNAs to Manage Metabolic Diseases
Current Pharmaceutical Design Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
Current Cancer Drug Targets Current Understanding of the Potential of Proteomics and Metabolomics Approaches in Cancer Chemoresistance: A Focus on Multiple Myeloma
Current Topics in Medicinal Chemistry Glucose Oncometabolism of Esophageal Cancer
Anti-Cancer Agents in Medicinal Chemistry Role of Natural Phenolic Compounds in Cancer Chemoprevention via Regulation of the Cell Cycle
Current Pharmaceutical Biotechnology An Up-date of Olive Oil Phenols in Inflammation and Cancer: Molecular Mechanisms and Clinical Implications
Current Medicinal Chemistry State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
Recent Patents on Anti-Cancer Drug Discovery The Role of Androgen Receptor Mutations in Prostate Cancer Progression
Current Genomics Killing Glioma ‘Stem-like’ Cells via Drug-Induced Relocation of Endosomal Urokinase Proteins
Anti-Cancer Agents in Medicinal Chemistry Biomedical Applications of Poly(Lactic Acid)
Recent Patents on Regenerative Medicine Imatinib Mesylate for the Treatment of Solid Tumours: Recent Trials and Future Directions
Current Enzyme Inhibition Recent Patents Reveal Microtubules as Persistent Promising Target for Novel Drug Development for Cancers
Recent Patents on Anti-Infective Drug Discovery The Role of Stress Proteins in Prostate Cancer
Current Genomics Long Non-Coding RNAs As Epigenetic Regulators in Cancer
Current Pharmaceutical Design Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Nitrosative Stress as a Mediator of Apoptosis: Implications for Cancer Therapy
Current Pharmaceutical Design HCN Channels Modulators: The Need for Selectivity
Current Topics in Medicinal Chemistry